Additionally, semaglutide GLP-1 slows down the rate at which your stomach empties after eating, which contributes to a decrease in appetite and caloric intake
Its generally mild and tends to go away within the first few weeks as your body adjusts to the medication
Theres no reason to stop a medication that is otherwise working well. Oral side effects on semaglutide, tirzepatide, and other GLP-1s occur often enough to be worth talking about
Liraglutide is additionally approved for the treatment of obesity, at a dose of 3.0 mg (128), while semaglutide is in clinical development as a treatment for obesity (phase 3) and NASH (phase 2)
Summary of Tirzepatide's Effects and Mechanism of Action Tirzepatide is a dual agonist that acts on both the GIP and GLP-1 receptors
A., Sparasci, O., Parkes, L